---
title: "Xolair (omalizumab), all indications: Dosing and administration questions"
description: "Dosing and administration questions on Xolair (omalizumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Administration and Preparation. Questions: Where is Xolair injected? Can children under 12 use the Xolair autoinjector? How is the Xolair 150 mg vial reconstituted? 3 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/xolair/dosing-and-administration"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Xolair (omalizumab), all indications: Dosing and administration questions

Manufacturer: Genentech, Inc.; Novartis Pharmaceuticals Corporation  
Prescribing information: [Xolair](https://www.gene.com/download/pdf/xolair_prescribing.pdf)  
Indication pages: [Allergic asthma](https://www.evicenter.com/medical-information/xolair--allergic-asthma)

## Administration

<a id="xolair-injection-sites"></a>

### Where is Xolair injected?

> “Administer subcutaneous injection into the thigh or abdomen, avoiding the 2-inch (5 
> cm) area directly around the navel. The outer area of the upper arms may be used 
> only if the injection is being given by a caregiver or healthcare provider [see 
> Instructions for Use].  The injection may take up to 15 seconds to administer.”

Source: [XOLAIR: Prescribing information, page 10, captured 2026-11-13](https://www.gene.com/download/pdf/xolair_prescribing.pdf#page=10)

> “For patients requiring more than 1 injection to complete a full dose, administer each 
> injection at least 1 inch apart from other injection sites.”

Source: [XOLAIR: Prescribing information, page 10, captured 2026-11-13](https://www.gene.com/download/pdf/xolair_prescribing.pdf#page=10)

> “Administer XOLAIR by subcutaneous injection. The injection may take 5-10 seconds 
> to administer because the solution is slightly viscous. Do not administer more than 150 
> mg (contents of one vial) per injection site. Divide doses of more than 150 mg between 
> two or more injection sites.”

Source: [XOLAIR: Prescribing information, page 12, captured 2026-11-13](https://www.gene.com/download/pdf/xolair_prescribing.pdf#page=12)

Note: The first two passages concern the prefilled syringe and autoinjector; the third is the label's instruction for the reconstituted vial.

<a id="xolair-autoinjector-children"></a>

### Can children under 12 use the Xolair autoinjector?

> “Adolescents 12 years of age and older: XOLAIR prefilled syringe may be self-
> administered under adult supervision. 
>
> • Pediatric Patients 1 to 11 years of age: XOLAIR prefilled syringe should be 
> administered by a caregiver.  
>
> XOLAIR Autoinjector 
>
> • Adolescents 12 years of age and older: XOLAIR autoinjector may be self-
> administered under adult supervision. The XOLAIR autoinjectors (all doses) are 
> intended for use only in adults and adolescents aged 12 years and older. 
>
> • Pediatric Patients 1 to 11 years of age: The XOLAIR autoinjectors (all doses) are not 
> intended for use in pediatric patients under 12 years of age.”

Source: [XOLAIR: Prescribing information, page 10, captured 2026-11-13](https://www.gene.com/download/pdf/xolair_prescribing.pdf#page=10)

Note: The label groups pediatric patients 1 to 11 years of age because it covers every indication; the asthma indication begins at 6 years of age.

## Preparation

<a id="xolair-vial-reconstitution"></a>

### How is the Xolair 150 mg vial reconstituted?

> “Draw 1.4 mL of SWFI, USP, into a 3 mL syringe equipped with a 1-inch, 18-gauge 
> needle.”

Source: [XOLAIR: Prescribing information, page 12, captured 2026-11-13](https://www.gene.com/download/pdf/xolair_prescribing.pdf#page=12)

> “Gently swirl the vial for 5 to 10 seconds approximately every 5 minutes in order to 
> dissolve any remaining solids.  The lyophilized product takes 15 to 20 minutes to 
> dissolve.  If it takes longer than 20 minutes to dissolve completely, gently swirl the vial 
> for 5 to 10 seconds approximately every 5 minutes until there are no visible gel-like 
> particles in the solution.  Do not use if the contents of the vial do not dissolve 
> completely by 40 minutes.”

Source: [XOLAIR: Prescribing information, page 12, captured 2026-11-13](https://www.gene.com/download/pdf/xolair_prescribing.pdf#page=12)

> “Use the XOLAIR solution within 8 hours following reconstitution when stored in 
> the vial at 2ºC to 8ºC (36ºF to 46ºF), or within 4 hours of reconstitution when 
> stored at room temperature.  Reconstituted XOLAIR vials should be protected from 
> sunlight.”

Source: [XOLAIR: Prescribing information, page 12, captured 2026-11-13](https://www.gene.com/download/pdf/xolair_prescribing.pdf#page=12)

Note: The passages are steps 2, 5, and 8 of the label's preparation instructions for the lyophilized powder.

## Related pages
- [Medical information: Xolair (omalizumab): All indications](https://www.evicenter.com/medical-information/xolair)
- [Indication](https://www.evicenter.com/medical-information/xolair/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/xolair/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/xolair/safety)
- [Storage and supply](https://www.evicenter.com/medical-information/xolair/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/xolair/access-and-coverage)
